OpenResearchAlpha

bioRxiv · 20 Nov 2026

Spatial metabolic ecosystems shape the architecture of IDH-mutant glioma

J. J. Moffet, J. Kriel, T. Lu, M. Spiteri, O. E. Fatunla, A. L. Valkovic, J. F. Pignatelli, Z. Moore, B. Kumar, S. Portelli, L. A. Riley, V. K. Narayana, B. Nijagal, J. J. Jones, S. A. Cain, S. J. Roberts-Thompson, M. Li, K. J. Drummond, M. J. McConville, D. M. Ashley, J. R. Whittle, S. Freytag, S. A. Best

0
Citations
no database records one yet
0
Citations in 2026
so far
–
Leading author's h-index
no author has a profile yet
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

The principles governing tissue organization in IDH-mutant glioma remain poorly understood, particularly in the absence of hypoxia and necrosis that define IDH-wildtype glioblastoma. Here, we integrated spatial transcriptomics, metabolomics and histology across co-registered serial tissue sections, generating a multidimensional atlas of IDH-mutant glioma. Integration with an independent spatial transcriptomics cohort and a single cell atlas (n=101 samples), enabled resolution of metabolic and cellular heterogeneity underlying tissue organization. We identified twelve conserved spatial niches with distinct metabolic identities that could not be explained by cellular composition or histology alone. Beyond these ecosystems, we discovered a transcriptionally and epigenetically intermediate malignant cell state enriched in WHO grade 2/3 oligodendroglioma, and spatially segregated myeloid programs. Importantly, progression following chemoradiotherapy was associated with expansion of a glutathione-rich, NRF2-associated antioxidant niche. Together, our findings establish metabolic specialization as a fundamental dimension of glioma organization, providing new insight into tumor heterogeneity, progression and treatment-associated adaptation.

Cancer biology

What the data shows

  • No database records a citation yet, as is usual for a paper this new.

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (23)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.